Wed, 10/14/2009 - 14:54
Servier Laboratories aiming high in China's innovative drug market - Servier China GM
by Yu Chenxi
Thirty years after Servier Laboratories first entered the Chinese market, we spoke to Pony Lu, general manager of Servier China, on the company's growth opportunities and development strategy in the years to come.
"In China, our R & D is focused on molecular drugs derived from traditional Chinese medicines," said Pony, manager of Servier China.
Shanghai. October 14. INTERFAX-CHINA - Servier Laboratories aims to increase research and development (R & D) investment in China and to deepen collaboration with Chinese medical research institutions over the next five years, Pony Lu, general manager of Servier China, recently told Interfax.
